Synergy between parthenolide and arsenic trioxide in adult T-cell leukemia/lymphoma cells in vitro
<em><strong>Objective(s):</strong></em> Adult T-cell leukemia/lymphoma (ATLL) is an aggressive lymphoid malignancy with low survival rate and distinct geographical distribution. In search for novel chemotherapeutics against ATLL, we investigated the combinatorial effects of p...
Main Authors: | Hamideh Kouhpaykar, Mohammad Hadi Sadeghian, Houshang Rafatpanah, Mohadeseh Kazemi, Mehrdad Iranshahi, Zahra Delbari, Faezeh Khodadadi, Hossein Ayatolahi, Fatemeh B. Rassouli |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2020-05-01
|
Series: | Iranian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | http://ijbms.mums.ac.ir/article_14630_e21494ea546f5116aef975b291183715.pdf |
Similar Items
-
Parthenolide and arsenic trioxide co-trigger autophagy-accompanied apoptosis in hepatocellular carcinoma cells
by: Juan Yi, et al.
Published: (2022-10-01) -
Combination of auraptene and arsenic trioxide induces apoptosis and cellular accumulation in the subG1 phase in adult T-cell leukemia cells
by: Mohaddeseh Kazemi, et al.
Published: (2021-12-01) -
Comparing cytotoxicity of parthenolide, melphalan, and procarbazine in colon adenocarcinoma and hepatocellular carcinoma cells
by: Fatemeh B. Rassouli
Published: (2018-08-01) -
Parthenolide: suggested drug for COVID-19
by: M. Nemati, et al.
Published: (2020-11-01) -
Parthenolide Induces Reactive Oxygen Species-Mediated Autophagic Cell Death in Human Osteosarcoma Cells
by: Chen Yang, et al.
Published: (2016-11-01)